BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for Mersana Therapeutics, Inc. (MRSN)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Mersana Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-02-11
5:08 pm
Sale		 2020-12-31 13G Mersana Therapeutics, Inc.
MRSN		 BIOTECHNOLOGY VALUE FUND L P 0
0.000%		 -3,755,553decrease
(Position Closed)		 Filing